摘要: |
[目的]提高siRNA表达载体在肝星状细胞(hepatic stellate cells,HSCs)中的转染效率。[方法]pEGFP-C1-CR4转染原代HSCs、HSC-T6细胞株,实验根据质粒DNA和阳离子脂质体的不同比例分为4组: 1 μg/0 μL、1 μg/1 μL、1 μg/2 μL、1 μg/4 μL,1μg/0 μL为对照组,其余3组为实验组。转染48 h后,使用荧光显微镜观察转染情况,同时流式细胞仪计算转染效率。[结果] 质粒DNA和阳离子脂质体的比例为1 μg/2 μL和1 μg/4 μL时,原代HSCs转染效率为(56.55±3.12)%和(58.62±2.03)%(P>0.05),HSC-T6细胞株转染效率为(24.52±3.55)%和(25.49±2.33)%(P>0.05)。同样比例条件下,原代HSCs的转染效率显著高于HSC-T6细胞株的转染效率(P<0.05)。在实验组质粒、脂质体比例为1 μg/2 μL和1 μg/4 μL时,同种细胞的转染效率均无显著差别(P>0.05)。[结论]采用质粒DNA和阳离子脂质体的比例为1 μg/2μL、1 μg/4 μL的条件,均能够在HSCs和HSC-T6中获得最佳转染效率,但前者更为经济。 |
关键词: RNA干扰 肝星状细胞 肝纤维化 基因转染 |
DOI:10.11724/jdmu.2006.03.04 |
分类号:R73 |
基金项目: |
|
Detection of Smad2 targeted siRNA transfection efficiency in hepatic stellate cells |
LUO Hai-feng, WANG Hong-jiang, WANG Zhong-yu
|
Department of General Surgery, the First Affiliated Hospital,Dalian Medical University Dalian 116011, China
|
Abstract: |
[Objective] To increase the transfection efficiency of siRNA expression constructs transfection in hepatic stellate cells in vitro. [Methods] HSCs and HSC-T6 cell line were transfected with pEGFP-C1-CR4 plasmid DNA. According to the different ratio of plasmid DNA/Lipofectamine 2000 (Life technologies), the transfection protocols were divided into 4 groups: naked DNA, 1 μg/1 μL, 1 μg/2 μL and 1 μg/4 μL. 48 hours later, transfection efficiencies of different protocols were evaluated by fluorescent microscopy observation and flow cytometer counting. [Results] The transfection efficiencies in 1 μg/2 μL and 1 μg/4 μL groups were (56.55±3.12)% and(58.62±2.03)% in primary HSCs(P>0.05), (24.52±3.55)% and(25.49±2.33)% in HSC-T6 cell line(P>0.05). The efficencies were significant higher in HSCs than those in HSC-T6 cell line (P<0.05). There was no significant difference on each kind of cell between the 1 μg/2 μL and 1μg/4μL groups in efficacy(P>0.05). [Conclusion] In our study, 1 μg/2 μL (DNA /LIPO) is the most economical and optimal ratio to get best transfection efficiency in HSCs and HSC-T6 cell line. |
Key words: RNA interference (RNAi) hepatic stellate cytes(HSCs) liver fibrosis gene transfection |